WANBURY
|
The Current P/B Ratio of WANBURY is 37.29.
Share Price | ₹239.9 | Jan 10,2025 |
Market Cap | ₹786.9 Cr | |
Book Value | ₹21.1 Cr | Mar2024 - Consolidated Results |
Price/Book | 37.29x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of WANBURY
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹786.9 Cr] as on Jan 10,2025
(/) Book Value [ ₹21.1 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 37.29x ]
Thus, for WANBURY , the investors are currently willing to pay '37.29 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WANBURY !
The chart below summarizes the trend in P/B Ratio of WANBURY over the last five years.
Historical PB (Price/Book ) ratio chart of WANBURY
PB Ratio Performance Analysis for WANBURY
- WANBURY 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- WANBURY 's operated at median p/b ratio of -1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/b ratio peaked in Mar2024 at 22.63x.
- WANBURY 's p/b ratio hit its five-year low in Mar2022 of -11.25x.
How does WANBURY 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
WANBURY | 21.10 | 37.29 | 786.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.73 | 428,533.0 |
CIPLA LTD | 26,619.90 | 4.46 | 118,723.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.02 | 112,998.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.09 | 101,031.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.28 | 153,076.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.10 | 112,971.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.17 | 110,870.0 |
LUPIN LTD | 14,175.80 | 7.05 | 99,938.2 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.34 | 69,702.0 |
ABBOTT INDIA LTD | 3,658.73 | 16.72 | 61,179.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WANBURY 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.34x |
Max industry PB | 37.29x |
Median industry PB | 7.05x |
Average industry PB | 11.20x |
You may also like the below Video Courses